Skip to main content
Clinical Trials/NCT04011813
NCT04011813CompletedNot Applicable

Official Title: Hypotaurine Supplementation in Freezing and Preparation Media Improves Human Sperm DeoxyriboNucleic Acid (DNA) and Fertilizing Ability

University Hospital, Clermont-Ferrand0 sites33 target enrollmentStarted: May 1, 2014Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
33
Primary Endpoint
chromatin packaging labelled using aniline blue and chromomycin A3

Study Overview

Brief Summary

Although it is widely used, slow freezing can induce strong functional and nuclear spermatic alterations reducing the chances of pregnancy. The study objective is to determinate the effects of the combination of hypotaurine supplementation and spermatozoa selection by Density Gradient Centrifugation (DGC) on human sperm functions and DNA quality during a freezing-thawing cycle.

Detailed Description

This prospective study was performed on surplus semen after a density gradient centrifugation-frozen-thawing cycle. Samples were obtained from men undergoing routine semen analysis at the Center for Reproductive Medicine. Spermatozoa were selected by density gradient centrifugation, washed and frozen using a programmable device. Each step was performed in parallel with (H+ arm) or without (H- arm) 50mM hypotaurine supplementation. After thawing, investigator team compared for both conditions the total and progressive mobility, vitality, integrity of the acrosome, markers of Protein Kinase A (PKA) dependent capacitation intracellular signaling pathway and nuclear quality by measuring chromatin packaging, DNA fragmentation and oxidation and vacuoles presence in the spermatozoa head.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
Male
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Arms & Interventions

Control arm, "H-"

semen treated without hypotaurine supplementation in density gradient centrifugation, washing and cryopreservation media

Experimental arm, "H+"

semen treated with a 50mM hypotaurine supplementation in density gradient centrifugation, washing and cryopreservation media

Intervention: Hypotaurine : antioxidant and osmoregulator (Other)

Outcomes

Primary Outcomes

chromatin packaging labelled using aniline blue and chromomycin A3

Time Frame: Day 0

Comparison after a cycle of freezing-thawing for both conditions, with or without hypotaurine supplementation of chromatin packaging labelled using aniline blue and chromomycin A3

DNA fragmentation using TUNEL assay

Time Frame: Day 0

Comparison after a cycle of freezing-thawing for both conditions, with or without hypotaurine supplementation of DNA fragmentation using TUNEL assay

DNA oxidation assessed by 8-OHdG immunodetections

Time Frame: Day 0

Comparison after a cycle of freezing-thawing for both conditions, with or without hypotaurine supplementation of DNA oxidation assessed by 8-OHdG immunodetections

vacuoles presence in the spermatozoa head using Motile Sperm Organelle Morphology Examination (MSOME)

Time Frame: Day 0

Comparison after a cycle of freezing-thawing for both conditions, with or without hypotaurine supplementation of vacuoles presence in the spermatozoa head using Motile Sperm Organelle Morphology Examination (MSOME)

Secondary Outcomes

  • motility total and progressive(Day 0)
  • vitality using Eosin Nigrosin(Day 0)
  • markers of PKA-dependent capacitation intracellular signaling pathway assessing western blot(Day 0)
  • integrity of the acrosome using Fluorescein IsoThioCyanate-Pisum Sativum Agglutinin (FITC-PSA) labelling(Day 0)

Investigators

Sponsor
University Hospital, Clermont-Ferrand
Sponsor Class
Other
Responsible Party
Sponsor

Similar Trials

Hypotaurine Supplementation Benefits in... | Clinical Trial